Current Research and Scholarly Interests
Hodgkin lymphoma: Dr. Glaser has conducted numerous studies in the epidemiology of Hodgkin lymphoma, including descriptive analyses and population-based studies in women and to characterize the epidemiologic features of Epstein-Barr virus (EBV)-associated Hodgkin lymphoma. With colleagues Dr. Richard Ambinder and Dr. Margaret Gulley, Dr. Glaser evaluated the reliability of EBV detection assays, generating interpretation guidelines to minimize this variation. Dr. Glaserís current research interests in Hodgkin lymphoma involve genetic determinants of risk and their interaction with environmental factors.
Breast cancer: Dr. Glaser has been involved in numerous studies of incidence and survival patterns of breast cancer. Her analytic studies have focused on immune function modulators.
Surveillance Research: Within the Greater Bay Area Cancer Registry, part of the NCI's SEER program, Dr. Glaser built a research program dedicated to the insightful use of population-based cancer registry data to inform understanding of site-specific cancer incidence and survival patterns in various population subgroups, particularly those defined by race/ethnicity and socioeconomic status. This program has had particular interest in breast, colon and prostate cancers, and in lymphomas, as well in examining racial/ethnic and birthplace disparities in cancer incidence and survival.
Registry leadership: Dr. Glaser has been the Director of the Greater Bay Area Cancer Registry since 2005. She and her registry team are committed to excellence in registry function and to preparing for changes facing cancer registration, including increasing electronic data transmission and expanding data content to include more information on biomarkers, comorbidities and intermediate endpoints such as recurrence.
Dr. Glaser served as the leader of the Cancer Prevention Institute of California from 2008 through 2013.